Kaitlyn R. Calabro

Biochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Development of an AAV-CRISPR-Cas9-based treatment for dominant cone-rod dystrophy 6”.

Development of an AAV-CRISPR-Cas9-based treatment for dominant cone-rod dystrophy 6

Molecular Therapy — Methods & Clinical Development(2023)10.1016/j.omtm.2023.05.020

N/A

0.401DataRank · unranked

8 citations

Kaitlyn R. Calabro, K. Tyler McCullough, Sean M. Crosson, Alejandro de la Cova, Diego Fajardo +3 more

Novel AAV44.9-Based Vectors Display Exceptional Characteristics for Retinal Gene Therapy

Molecular Therapy(2020)10.1016/j.ymthe.2020.04.002

N/A

0DataRank · unranked

28 citations

Shreyasi Choudhury, Sean M. Crosson, Giovanni Di Pasquale, Sandra Afione, Russell Mellen +11 more

Dual-AAV vector-mediated expression of MYO7A improves vestibular function in a mouse model of Usher syndrome 1B

Molecular Therapy — Methods & Clinical Development(2023)10.1016/j.omtm.2023.08.012

N/A

0DataRank · unranked

22 citations

M’hamed Grati, Kevin Isgrig, Moaz Sinan, Kaitlyn R. Calabro, Jianliang Zhu +9 more

Optimization of Capillary-Based Western Blotting for MYO7A

Advances in experimental medicine and biology(2023)10.1007/978-3-031-27681-1_19

N/A

0DataRank · unranked

0 citations

Sanford L. Boye, Kaitlyn R. Calabro

Development of an AAV-based gene therapy for the ocular phenotype of Friedreich’s ataxia

Molecular Therapy(2025)10.1016/j.ymthe.2025.10.048

N/A

0DataRank · unranked

1 citations

Siddhant Gupte, Emily Xu, Kaitlyn R. Calabro, Hannah Friend, Sean M. Crosson +10 more